Table 2.
Plasma biomarkers predicting stroke and ICH
Stroke at baseline | ICH at baseline | Incident stroke | Incident ICH | |||||
---|---|---|---|---|---|---|---|---|
aOR (95% CI)* | p value | aOR (95% CI)* | p value | HR (95% CI)† | p value | HR (95% CI)† | p value | |
NfL | 2.02 (1.06–3.87) | 0.03 | 1.17 (0.76–1.81) | 0.48 | 1.93 (1.19–3.13) | 0.01 | 2.39 (1.21–4.70) | 0.01 |
GFAP | 2.51 (0.92–6.89) | 0.07 | 2.06 (1.26–3.35) | 0.004 | 1.62 (0.92–2.85) | 0.09 | 2.80 (1.21–6.53) | 0.02 |
Tau | 1.52 (0.85–2.71) | 0.15 | 1.23 (0.76–1.99) | 0.40 | 0.74 (0.37–1.47) | 0.39 | 1.36 (0.61–3.04) | 0.45 |
UCHL1 | 1.28 (0.72–2.28) | 0.39 | 1.74 (0.995–3.06) | 0.05 | 1.42 (0.80–2.52) | 0.23 | 1.61 (0.86–3.02) | 0.14 |
Numbers in bold indicate statistical significance
aOR adjusted odds ratio, GFAP glial fibrillary acidic protein, HR hazard ratio, ICH intracerebral hemorrhage, NfL neurofilament light chain, UCHL1 ubiquitin carboxy-terminal hydrolase L1
*Logistic regression models adjusted for age, sex, and hypertension. †Cox regression models adjusted after age, sex, and history of intracerebral hemorrhage at baseline